Gut stromal tumors and their clinical behavior

Area of Science:

• Gastroenterology
• Surgical Oncology
• Gastrointestinal Pathology

Background:

• Gut stromal tumors (GST) are intramural intestinal neoplasms, previously termed leiomyoma and leiomyosarcoma.
• Understanding GST behavior, clinical outcomes, and indications for surgical intervention is crucial.

Purpose of the Study:

• To investigate the clinical sequelae of gut stromal tumors.
• To determine the correlation between tumor size and presenting symptoms.
• To establish indications for the surgical excision of GST.

Main Methods:

• A retrospective analysis of 39 GST patients diagnosed between 1988 and 1996.
• Inclusion of long-term follow-up data for all analyzed patients.

Main Results:

• GST occurred in the stomach or small intestine in 95% of cases, with 77% being benign.
• Tumor size correlated with symptoms: small tumors (<2 cm) were incidental, while larger tumors (average 6 cm) were symptomatic.
• Symptomatic patients experienced significant morbidity, including gastrointestinal bleeding (70%), abdominal pain (57%), obstruction (30%), and perforation (9%).

Conclusions:

• Gut stromal tumors, though uncommon, can lead to substantial patient morbidity.
• Complete surgical excision is recommended for all GST, regardless of incidental discovery, due to the risk of complications in symptomatic cases.
• Small, incidentally discovered GST (<2 cm) showed no recurrence after resection.